Related Links Educational Materials About Clinical Trials Clinical Trials: Questions and Answers Questions to Ask Your Doctor Drug Information from MedlinePlus

Alternate Title
Basic Trial Information
Trial Description
     Purpose
     Eligibility
     Treatment/Intervention
Trial Contact Information
Registry Information

Alternate Title

Randomized Study of the Early Detection of Breast and Cervical Cancer in Women in India

Basic Trial Information

Phase Type Status Age Sponsor Protocol IDs Phase II Educational/Counseling/Training, Screening Active 35 to 64 NCI TATA-1900215717A1 1900215717A1, NCT00632047

Trial Description

Purpose:

Health education programs and screening methods, such as clinical breast examination and examination of the cervix, may help reduce the number of women who develop breast cancer and cervical cancer.

This randomized clinical trial is studying the early detection of breast cancer and cervical cancer in women in India.

Eligibility:

Eligibility criteria include the following:

• 35-64 years old
• Lives in Mumbai, India
• For more information about the eligibility criteria for this trial, refer to the Health Professional version.

Final eligibility for a clinical trial is determined by the health professionals conducting the trial.

Treatment/Intervention:

Participants will be randomly assigned (have an equal chance of being placed) to one of two groups.

Participants in group one will receive health education programs and undergo clinical breast examination and examination of the cervix every 2 years for up to 8 years. They will also undergo surveillance for 8 years.

Participants in group two will receive one health education program. They will also undergo surveillance for 8 years.

Important:

For more details about this trial, refer to the Health Professional version of the trial summary.

If you are interested in participating in a clinical trial, contact your doctor for a referral or call a trial contact person listed below. You may see the same contact person listed at more than one site, however, if you call the number listed you can ask to speak to the study coordinator or person involved with the specific trial you are interested in. If you have questions about cancer or clinical trials, call the Cancer Information Service at 1-800-4-CANCER (1-800-422-6237). General information about clinical trials, including risks, benefits, and costs, can be found on NCI's Web site.

Trial Contact Information

Trial Lead Organizations

Tata Memorial Hospital

Gauravi Mishra, MD, Principal investigator		Ph: 91-22-2415-7532

India
	Mumbai
	Tata Memorial Hospital
		Gauravi Mishra, MD	Ph:  91-22-2415-7532

Registry Information
Official Title		Early Detection of Common Cancers in Women in India
Trial Start Date		1998-05-04
Trial Completion Date		2015-12-31 (estimated)
Registered in ClinicalTrials.gov		NCT00632047
Date Submitted to PDQ		2008-02-07
Information Last Verified		2008-12-28
NCI Grant/Contract Number		CA074801